Delivery Order SPE2DB20D2104-SPE2DB24FU45Y

Award Date 5/30/24
Potential Completion Date 5/31/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,627.41 firm fixed price delivery order is for the supply of ARANESP 500 MCG/1 ML SYRINGEML, a specialty medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,553.92 delivery order contract is for the supply of ARANESP 200 MCG/0.4 ML SYRINGE 0.4ML, a specialty medication. The contract is a Firm Fixed Price arrangement with a performance period through March 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) between...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,376.14, is for the delivery of ARANESP 60 MCG/0.3 ML SYRINGE 0.3ML, a specialty medication. This is a Firm Fixed Price Delivery Order contract with a completion date of January 22, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of ARANESP 500 MCG/1 ML SYRINGEML, a specialty medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The $8,692.69 firm fixed price delivery order is a part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,085.34 Firm Fixed Price delivery order is for the supply of ARANESP 60 MCG/0.3 ML SYRINGE 0.3ML, a specialty pharmaceutical product. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. This single-award IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,769.52 firm-fixed-price delivery order is for the supply of Aranesp 200 mcg/0.4 ml syringes. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
This federal contract award, valued at $4,576.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of Aranesp 500 MCG/1 ML syringes, a specialty medication. The contract has a firm fixed price and an ultimate completion date of December 24, 2024. This contract award is associated with a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,529.80 firm fixed-price delivery order is for the supply of Aranesp 500 MCG/1 ML syringes and has an ultimate completion date of November 7, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,552.76 Firm Fixed Price Delivery Order is for the supply of ARANESP 25 MCG/0.42 ML syringes. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,046.36, is for the supply of Aranesp 40 mcg/0.4 ml syringes, a specialty medication used for the treatment of anemia. The contract is a firm fixed-price arrangement with a completion date of February 20, 2025. This contract is part of a larger Indefinite...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FU45Y
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,850.24 Firm Fixed Price Delivery Order is for the supply of ARANESP 200 MCG/0.4 ML SYRINGE 0.4ML, a medication used in the treatment of anemia.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, which runs through November 2026, encompasses critical medical commodities across multiple therapeutic areas.

The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, is responsible for delivering the specified pharmaceutical product to the government. This contract supports the DLA's mission of providing medical supplies and equipment to the U.S. military, veterans, and other federal beneficiaries.

Generated 2/27/25, 11:04 AM